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DEFINITION OF TERMS 
 
 
Allometric Model  A mathematical procedure used to establish a proper relationship between a 
body size variable and some other related factor of interest. The technique is used to provide 
proper statistical adjustment to evaluate the relative contribution of diverse independent 
variables. 
BMI  Body mass index is a measure derived from body mass and stature used to access the 
normalcy of a persons body weight. BMI = weight (kg) / height (m2).  
BTPS  Body Temperature (37C), pressure, saturated with water vapor.   
DLCO- A test that measures the lungs capacity to diffuse carbon monoxide (CO). The diffusing 
capacity is equal to CO uptake per unit time divided by the mean pressure of gradient for CO 
between alveolar gas and capillary blood. 
ERV- Expiratory Reserve Volume.  The maximum amount of air that can be forcefully exhaled 
after a quiet expiration has been completed, i.e., from the end-expiratory position. 
FEF25%-75% - Forced Mid-Expiratory Flow also know as the Mean Mid Expiratory Flow  
The mean amount of flow measured during the middle half of the forced vital capacity 
maneuver. 
FEV1- Forced Expiratory Volume One Second. - The amount of volume (liters) measured in the 
first second of the forced vital capacity maneuver. 
FEV1/FVC%.  The ratio of the FEV1 to FVC used in the analysis of different types of lung 
disease, i.e., restrictive versus obstructive.   
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FEV3- Forced Expiratory Volume Three Seconds. - The amount of volume (liters) measured in 
the beginning three seconds of the forced vital capacity maneuver. 
Flow-Volume Loops.   Graphic representation of the relationship between airflow and lung 
volumes during maximal expiratory and inspiratory maneuvers. 
FVC- Forced Vital Capacity.  The maximum volume of air (liters) that is exhaled as rapidly, 
forcefully and completely as possible form the point of maximum inhalation. 
FRC  Functional Residual Capacity.  The volume of air that remains in the lungs at the 
end of a normal expiration. 
IC  Inspiratory Capacity.  The maximum amount of air that can be inhaled from the end-
expiratory position.  It is comprised of the tidal volume (TV) and the inspiratory reserve volume 
(IRV). 
IRV  Inspiratory Reserve Volume.  The maximum amount of air that can be inhaled from the 
end of a tidal volume (TV) inhalation. 
MEP  Maximum Expiratory Pressure.  The maximum pressure that can be generated by a 
forceful expiration from total lung capacity measured in mmH2O. Used to measure expiratory 
muscle strength. 
MIP  Maximum Inspiratory Pressure.  The maximum pressure that can be generated by a 
forceful inspiration from residual volume (RV) measured in mmH2O. Used to measure 
inspiratory muscle strength. 
MVV  Maximum Voluntary Ventilation. - The volume of air that can be exhaled during 
12 seconds of rapid, deep breathing. The actual volume is extrapolated to one minute and 
measured in liters/minute.   
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PEF  Peak Expiratory Flow.  The maximum amount of flow at peak expiration measured in 
liters per second or liters per minute. 
RV  Residual Volume.  The volume of air that remains in the lungs after a maximal expiratory 
effort. 
RV/TLC% - Residual Volume to Total Lung Capacity ratio.  The ratio of air that remains in the 
lungs after a maximal expiration (RV) to the total capacity of the lungs. Expressed as a percent 
and used to determine normal versus abnormal lung function. 
Spirometery.  A method employing various types of apparatuses used to measure the dynamic 
volumes and flows of the lungs. 
TLC- Total Lung Capacity.  The total volume of air contained in the lungs at the end of a 
maximal inspiration. 
TV  Tidal Volume.  The volume of air that is drawn into the lungs during inspiration from the 
end-expiratory position and also leaves the lungs passively during expiration during quiet 
breathing. 
VC  Vital Capacity.  The volume of air that is exhaled by a maximal expiration after a 
maximal inspiration. 
VO2max. - The maximum amount of oxygen that an individual is able to consume in a given 
amount of time at a measured workload. Measurement used to access aerobic fitness levels.   
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ABSTRACT 
 
 Purpose: To compare the pulmonary function of older runners with non-runners and also 
the population norms.  Method:  40 males ages 45 to 65 were compared for respiratory muscle 
strength, spirometry and maximum voluntary ventilation. Univariate and multivariate analysis (p 
< 0.05) were used to determine differences   Results: No significant differences in age, height, or 
respiratory muscle strength were found. A significant difference was found for weight and BMI 
with the non-runners having greater values.   The dependent variables of FVC, FEV1, FEF25-75%, 
PEF, and MVV resulted in a significant difference with the runners having greater values. A 
significant difference was also found for pulmonary function between runners and the general 
population. Conclusion: Continued and habitual aerobic exercise in the form of running in 45 to 
65 year old men resulted in pulmonary function values that were significantly greater than those 
of the non-runners and also greater than population norms.    
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INTRODUCTION 
 
 
 Numerous studies have shown that individuals who continue to engage in aerobic 
type endurance exercise throughout their lives can attain and maintain levels of 
physiological and aerobic fitness that compare with much younger individuals.   Hagberg, 
Yerg, and Seals (1988) found that it was not unusual for some older athletes to exhibit 
physiological capacities that were equal to if not better than those of young untrained 
individuals. Several studies have shown that VO2 max, maximal stroke volume, and body 
composition measures of older endurance trained athletes were superior when compared 
to their sedentary peers (Hagberg, Allen, Seals, Hurley, Ehsani & Holloszy, 1985; Heath, 
Hagberg, Ehsani, 1981). Other physiological parameters of older endurance athletes such 
as glucose tolerance, insulin sensitivity, and plasma lipid levels have also been shown to 
be equal to younger individuals and greater than those found in their sedentary peers  
(Allen, Seals, Hurley, Ehsani, & Hagberg, 1985; Seals, Allen, Hurley, Dalsky & Ehsani, 
1984; Seals, Hagberg, Allen, Hurley, Dalsky, Ehsani & Holloszy, 1984).  It is clear from 
the body of scientific evidence that exists on older aerobic athletes that many 
physiological benefits can be expected from continued participation in aerobic exercise.     
Pulmonary function is one of the physiological parameters where one might 
logically expect to find superior values in older endurance-trained athletes relative to 
their peers. The logic being that superior pulmonary function should be a contributing 
factor to the elevated maximal oxygen consumption (VO2 max) seen in many older 
endurance-trained athletes (Heath et al., 1981). By definition endurance athletes practice 
aerobic exercise.  Aerobic type endurance exercises are activities that involve the use of 
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large muscle groups for extended periods of time.  Examples include such activities such 
as cycling, swimming, cross-country skiing, rowing, in-line skating, jumping rope, 
bench-stepping, stair climbing and running.  Any of these activities preformed                                                 
with sufficient duration, intensity, and frequency will elicit cardiovascular or aerobic 
improvement that leads to an improved VO2 max (Brahler & Blank, 1995; Lotgering, van 
Doorn, Struijk, Pool & Wallenburget, 1991; Wallick, Porcari, Wallick, Berg, Brice & 
Arimond, 1995).  Aerobic fitness is traditionally measured as VO2 max or the maximum 
amount of oxygen that an individual is able to consume in a given amount of time at a 
measured workload.  The physiologic components that contribute to VO2max include 
hemoglobin concentration, blood volume, cardiac output, peripheral blood flow, aerobic 
metabolism and pulmonary ventilation (McArdle, Katch & Katch, 2001). Pulmonary                                       
ventilation is one of the main physiologic components of VO2max.  The minute ventilation 
(VE) or volume of air consumed is one of the parameters used to measure VO2max via 
open-circuit spirometry. Any increases in the measured minute ventilation (VE), a direct 
measure of pulmonary ventilation, will result in higher VO2max scores. When these two 
facts are considered it would seem reasonable to assume that superior pulmonary function 
should be a contributing factor to the higher than predicted VO2max found in endurance 
athletes.  Many factors have been shown to contribute to the enhanced aerobic capacity of 
highly trained athletes. Increases in blood plasma volume, heart stroke volume, cardiac 
output, oxygen extraction, improved blood flow and distribution, and improved buffering 
of lactate all contribute to the increased aerobic capacity of trained athletes (McArdle, 
Katch & Katch, 2001).  The role pulmonary ventilation plays in contributing to improved 
aerobic capacity has not been fully resolved. While improvement in pulmonary function 
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has been shown to enhance the ability to sustain high levels of ventilation it has shown 
little or no effect on maximum static or dynamic lung functions (Boutellier, 1998; 
Johnson, Saupe & Dempsey, 1992). Several studies have shown little or no improvement 
in pulmonary function with aerobic training. (Babcock & Dempsey, 1994; Grimby & 
Soderholm, 1963). However the majority of those studies were executed with young 
subjects whose ages were such that they were at or near their physiological peak. Another 
way of thinking about this is that the young athletes were either still physically maturing 
or had just reached their physical maturity and as a result their physiological parameters 
were at or near peak and had not yet begun to decline. Few studies have looked at the 
lung functions of older endurance athletes. The few that have looked at the lung functions 
of the older endurance athlete were either conducted with a small number of subjects or 
in some instances just singular case studies (Faria & Frankel, 1977; Maud, Pollock, 
Foster, Anholm, Guten, Al-Nouri, Hellman & Schmidt, 1981; Webb, Urner & 
McDaniels, 1977). Pulmonary lung function when measured as forced expiratory 
function has been repeatedly shown to decrease with advancing age in humans (Babb, 
1999; Pfitzenmeyer, Brondel, DArthis, Lacroix, Didier & Gaudet, 1993; Schmidt, 
Dickman, Gardner, & Brough, 1973).  Since pulmonary function is a physiological 
parameter that declines with aging it is possible that endurance aerobic exercise will 
prevent or slow the natural decline when practiced over an extended time period. 
Pulmonary lung function is commonly assessed by spirometry. The test results are 
usually compared against population norms derived from regression equations resulting 
from large-scale studies.  Predictive norms for pulmonary functions have been 
established for many different population groups (Birath, Kjellmer & Sandqvist, 1963; 
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Black & Hyatt, 1969; Crapo, Morris, Clayton & Nixon, 1982; Ferris, Anderson & 
Zickmantel, 1965; Gison, Pride, OCain & Quagliato, 1976; Goldman, & Becklake, 
1959; Grimby & Soderholm, 1963, Grimby & Saltin, 1966; Kory, Callahan, Boren & 
Syner, 1961; Morris, Koski & Johnson, 1971; Needham, Rogan & McDonald, 1954; 
Norris, Shock, Landowne & Falzone, 1956).  Normative values for pulmonary lung 
functions are established after testing very large numbers of individuals with similar 
characteristics and then deriving predictive equations through the use of regression 
statistics.  The major grouping characteristics for pulmonary functions include height, 
weight, age, sex, and ethnicity.  Subjects are tested and their scores are reported as 
percent of predicted. The American Thoracic Society (1987) is the governing body that 
sets the standards for pulmonary function testing.   
 Lung volumes are divided into the following four divisions, tidal volume (TV), 
inspiratory reserve volume (IRV), expiratory reserve volume (ERV), and residual volume 
(RV).  These four volumes comprise the four capacities of the pulmonary system.  The 
total lung capacity (TLC) contains all four volumes and is the maximum amount of lung 
volume.  The vital capacity (VC) is the next largest and is comprised of three lung 
volumes, the IRV, TV, and the ERV. The inspiratory capacity (IC) is comprised of two 
volumes, the IRV and TV.  The functional reserve capacity (RFC) is comprised of two 
volumes, the ERV and the RV.  Parameters measured to assess lung function with simple 
spirometry include forced vital capacity (FVC), forced expiratory volume one second  
(FEV1), and three seconds (FEV3), ratio of FVC/FEV1, forced expiratory mid-flow 
(FEF25-75), maximum voluntary ventilation (MVV), and peak expiratory flow (PEF).  
Respiratory muscle strength is commonly assessed via negative inspiratory force (NIF) 
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and positive expiratory force (PEF) (Spearman, Sheldon & Egan, 1982).   
Purpose 
The primary purpose of this study was to compare the pulmonary function of 
older endurance trained athletes with that of age-matched non-aerobic exercising 
controls. The measured values of both groups were compared to established normative 
values. The results were used to determine if the practice of continuous aerobic exercise 
in the form of endurance running had any attenuating affect on the natural decline of 
pulmonary function.  The decline of pulmonary lung volume and function with age is a 
well-documented phenomenon (DeLorey & Babb, 1999; R.J. Knudson, Clark, Kennedy 
D.E. Knudson, 1977).  A secondary purpose was to determine if long-term aerobic 
exercise in the form of endurance running resulted in greater then expected pulmonary 
function for runners when compared to the general population.   
Hypotheses 
The first hypothesis of this study was that older individuals between the ages of 
45 and 65 years of age that had practiced continuing endurance running for a minimum of 
10 years would have significantly greater pulmonary function than age-matched 
individuals of similar characteristics who had not practiced endurance running or other 
types of aerobic exercise.  Specifically it was expected that the older endurance-trained 
athletes would have statistically significantly greater forced vital capacities (FVC), forced 
expiratory volumes at one second (FEV1), forced mid expiratory flows (FEF25-75), 
maximum voluntary ventilation (MVV), and greater negative inspiratory force (NIF) and 
positive expiratory force (PEF) when compared to the control subjects.  The second 
hypothesis was that the runners would have significantly greater   (p < 0.05) pulmonary 
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function values then the general population when matched for age, height, sex, and race 
as predicted by Knudsons (1983) pulmonary function prediction equations.  
Limitations 
 Limitations that may have affected the results of this study included but were not 
limited to the following possible reasons.  A small sample size of only 20 subjects in each 
group limited the power of the study.  Factors such as outlier values and unknown lung 
disease of any of the subjects could have confounded results.    Inaccurate self-report 
information may also have affected results. Finally the effort dependent nature of 
pulmonary function testing may have introduced error. Every effort was made to 
minimize error.  The spirometer was calibrated each day before testing (see Appendix D). 
Only one person, the principal investigator, performed all testing. Extensive practice 
testing was performed before the study began to familiarize the tester with the equipment 
and procedure.  Three different pretest subjects were tested and then retested to establish 
test reproducibility. Results were within +/- 3% for all three cases.  Validity was 
established by using proven, accepted methods and standards mandated by the American 
Thoracic Society for pulmonary function testing.  Sample spirometry reports can be 
found in Appendix E. 
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LITERATURE REVIEW 
 
The decline of certain pulmonary function parameters with age is a well-
documented phenomenon that has been the subject of many scientific studies.  The exact 
mechanisms responsible for this phenomenon have only been partially accounted for and 
explained in the research literature. The complex nature and multitude of variables 
involved in separating the singular effects of aging on pulmonary functions from all other 
factors such as environment, disease, genetics, and physical activity has complicated 
efforts to identify the affects due solely to aging.  
A retrospective review by Knudson et al., (1977) examined the pulmonary 
function and aging literature.  The authors found little consistency or agreement of 
findings in the literature related to the affects of aging upon pulmonary function. Some of 
the studies reviewed reported finding age related affects, some reported not finding any 
age related affects, and some were inconclusive in their findings.   Frank, Mead and 
Ferris (1957) found a loss of elastic recoil with aging but could not show that the loss of 
elastic recoil was due solely to aging.  Contrary to results published by Permutt and 
Martin (1960) who found no connection between loss of lung elasticity and aging. A 
subsequent study by Turner, Mead, and Wohl (1968) showed significant results 
indicating that loss of elastic recoil was related to aging.  According to Knudson et al. 
(1977) the problems with these studies and several others from the same era were the lax 
criteria for subject selection. Subjects were not screened closely enough for past history 
of respiratory disease or current or past smoking habits any of which could have 
confounded the results.  As a result of these contradictory findings Knudson et.al (1977) 
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designed a study that attempted to eliminate and control for variables not solely related to 
age. Initial screening included over three thousand subjects from a longitudinal 
epidemiological study on obstructive lung diseases with the final sample size reduced to 
51 subjects. Stringent protocols eliminated all subjects that had any history of lung 
disease, smoking, or abnormal pulmonary functions. The remaining subjects where then 
tested and determined to be alpha-1 antitrypsin MM phenotypes. People who are not 
alpha-1 antitrypsin MM phenotypes have a greater chance of certain inherited 
emphysema such as lung diseases.  Final selection resulted in 73 eligible subjects with 51 
full studies being completed. The subjects were placed into three different age groups 
delineated at 25-35, 36-64, and 65-75.  Spirometry and plethysmographic studies were 
conducted to produce pressure volume curves and determine lung volumes. The results 
showed the loss of elastic lung recoil existed with aging and was more significant 
(p=0.015) at higher rather than a lower lung volumes. The authors of this study 
concluded that while there was a statistically significant aging effect on lung function it 
was not profound and was less then half that reported by previous studies.   
DeLorey and Babb (1999) investigated the progressive mechanical ventilatory 
constraints associated with aging. Forty-five subjects of ages ranging from 36 to 90 years 
had their pulmonary functions measured each minute while performing graded cycle 
ergometry to exhaustion.  Minute ventilation (VE), lung volume, expiratory airflow 
limitation (EAFL), age and gender were the measured variables. The results showed a 
significant increase in end-expiratory lung volumes (EELV) that increased progressively 
with age.  The normal decrease in EELV usually seen in young, healthy subjects during 
the early stages of exercise was not present in the older subjects. DeLorey and Babb 
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(1999) concluded that aging showed significant (p<0.05) progressive mechanical 
ventilatory constraints that were significant during exercise.  In a related study Babb and 
Rodarte (2000) investigated the determinates of maximal expiratory flow (MEF) with 
aging. MEF was studied in young, middle age, and elderly subjects at 60. 70, 80, 90, and 
100% of total lung capacity. All subjects were screened for history of respiratory 
diseases. Standard spirometry and plethysmographic tests were performed on all subjects. 
The results showed significant (p<0.05) declines related to aging for maximal expiratory 
flow (MEF), static lung elastic recoil pressure (Pst), and minimal pressure for maximal 
flow (Pcrit).  Decreases in MEF were proportional to decreases found in Pst. Babb and 
Rodarte (2000) indicated that the major finding of their study was that decreases in MEF 
could be explained almost entirely by decreases in Pst.  Babb and Rodarte (2000) also 
found just as Knudson et al. (1977) had, that the changes in Pst at 90% and 100% of total 
lung capacity (TLC) were much smaller for men than for women of similar age. Greater 
respiratory muscle strength was suggested as a possible explanation for this finding.  
Further evidence that age-related changes in pulmonary architecture that included 
decreased elastic lung recoil, increased stiffness of chest wall, and reduced respiratory 
muscle strength result in decreased pulmonary function was shown by Dempsey and 
Seals (1995). The pressure generated by the recoil of the lung is closely related to the 
intra-airway pressure and as elastic recoil declines with age the result is airway closure at 
higher lung volumes.  The resulting decrease in expiratory flow coupled with decreased 
respiratory muscle strength accounts for the diminishing pulmonary functions, 
particularly FEV1, seen in the aging lung. A seven-year longitudinal study by Nihon, 
Kyobu, Shikkan, Gakkai and Zasshi (1997) measured the forced vital capacity (FVC) and 
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forced expiratory volume one second (FEV1) of 243 healthy Japanese men. They 
compared their findings with predicted values derived from regression equations 
generated from a previously conducted large cross-sectional study of Japanese adults. 
The results of their study showed average declines of only 22 mls per year for FVC and 
11 mls per year for FEV1. The predicted values for FVC and FEV1 generated from the 
regression equations were as much as 150% to 200% greater then the actual values. 
 Amara, Koval, Paterson and Cunningham (2001) used an allometric model to 
determine what factors were important to the decline in FEV1 found in subjects aged 55 
to 86 years.  The study was designed such that there were approximately 35 men and 35 
women in each 5-year age grouping (55-59, 60-64, etc.). All subjects had to be capable of 
walking a distance of 80 meters and living independently. Spirometry and handgrip 
strength tests were performed on all subjects.  Anthropometric measures of height, 
weight, and skinfold thickness were used to calculate body mass index (BMI) and fat-free 
mass (FFM) of subjects. Spirometry was limited to collecting forced expiratory volumes 
one-second (FEV1) using American Thoracic Society guidelines.  Physical activity was 
determined by administration of the Minnesota Leisure Time Physical Activity 
questionnaire (Taylor, Jacobs, Schucker, Knudsen, Leon & Debacker, 1978) and grip 
strength measured via a hand held dynamometer.  Regression analysis was used to 
examine the relationship between variables. The variables of height, age, sex, percent 
body fat, FFM, grip strength, and physical activity were placed in an allometric model 
proposed by Nevill and Holder (1995) to determine their influences on FEV1.  The 
following equation accounted for 47.3% of the variance found in FEV1: (lnFEV1 = 
1.578lnheight +  0.544lnFFM + 0.010lnPA  1.338  0.012age  0.083smoking status + 
  
 
11 
 
 
 
 
lnε).  FFM, grip strength and physical activity were incorporated as power functions in 
the model.  Amara et al. (2000) found a cross-sectional decline of 50 ml per year for men 
and 43 ml for women. As a group the subjects with greater FFM (p<0.01) and greater 
handgrip strength (p<0.01) had significantly higher FEV1 values.  Subjects with higher 
levels of physical activity showed a non-significant trend toward higher FEV1 values. The 
major finding of this study was that FFM had the greatest influence of FEV1 and 
demonstrated the contribution muscle mass has on pulmonary function in older subjects.    
Chen and Kuo (1989) examined the relationship between respiratory muscle 
function and age, sex and other factors. They investigated 160 subjects, 80 female and 80 
male, ranging from 16 to 75 years of age. Maximal inspiratory and expiratory pressures 
were measured to determine respiratory muscle strength along with standard spirometry 
to determine volumes and flows.  Their findings showed that there was a significant 
decline (p<0.05) in respiratory muscle strength and pulmonary function associated with 
aging.  They also found a significant positive (r = 0.29) relationship for inspiratory 
muscle endurance and physical activity.       
In general the majority of the recent pulmonary function literature indicates that 
pulmonary function declines with age. The primary decrease is due to loss of lung elastic 
recoil that leads to decreased lung volumes and flows. FVC and FEV1 have been shown 
to begin decreasing as early as the age of 40 and continuing to decrease with advancing 
age. Although a substantial number of studies have been done on the pulmonary function 
of normal, healthy and unhealthy older subjects, very little data exist on older endurance 
athletes.  The few studies that have been done were either case studies or studies 
involving small numbers of subjects and quite often had conflicting results and 
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conclusions.  
Hagberg et al. (1988) conducted a study with forty subjects. They compared the 
lung volumes and pulmonary functions of older endurance trained athletes against those 
of age-matched sedentary controls, young athletes, and young untrained athletes.  Their 
purpose was to determine if aerobic training had any affect on the age-associated changes 
in lung volumes and pulmonary functions. They found a significant difference (p<0.05) 
in the VO2 max between the older athletes and their age-matched sedentary controls.  
Maximal oxygen uptake (Vo2max) was 37% greater in absolute terms and 85% greater 
when expressed as per kilogram of body weight in older athletes when compared to their 
untrained peers. The older athletes weighed on average 20 kilograms less than the control 
subjects, thus accounting for the large difference between absolute and relative values. 
All lung volume and pulmonary variables were similar for these two groups on an 
absolute basis.  When values were normalized for height the athletes who were 12 
centimeters shorter on average had significantly  (p<0.05) larger values for vital capacity, 
FEV1, and total lung capacity.  The Vemax of the older athletes was 22% higher then their 
untrained peers however both groups had similar maximum voluntary ventilation scores 
resulting in a higher Vemax to MVV ratio for the older athletes.  The same trend was found 
when the young athletes were compared to their age matched sedentary controls. 
Maximum voluntary ventilation (MVV) and residual volume (RV) were also larger but 
not significant in the older athletes.  It is of interest to note that there were no differences 
found between the young athletes and their age-matched sedentary controls on either 
absolute or relative terms for any static lung volumes.  RV and RV/TLC % were the only 
variable larger in the older athletes compared to the younger athletes and all other lung 
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volumes and pulmonary functions were lower except TLC, which was the same for all 
groups.  The older athletes were the only group who had pulmonary functions that were 
significantly greater than their age-predicted norms.   
Previous to this study several other studies had compared the pulmonary function 
values of older endurance athletes to published age-related regression equation predicted 
norms.  While results have been somewhat mixed a general consensus exists that TLC, 
VC, FEV1, and MVV are larger in older endurance trained athletes then in age-matched 
peers (Grimby et al., 1966; Heath et al., 1981; Maud et al., 1981; Webb et al., 1977; 
Wilmore, Miller & Pollock, 1974).    The problem with most of these studies was small 
sample size; in some instances, they were only single case studies or poor subject 
selection.  Hagberg et al. (1988) used (N = 40) total subjects with 10 subjects in each age 
group and concluded from their findings that the older athletes had larger lung volumes 
and better pulmonary functions than their age-matched sedentary controls.  They also 
found no significant differences between lung volumes and pulmonary functions of the 
younger athletes and their age-matched controls.  The older athletes were the only group 
in the Hagberg study whose pulmonary function values were substantially greater then 
their predicted norms. Their assumption was that the type and duration of endurance 
exercise practiced by the older athletes had slowed the rate of deterioration of pulmonary 
function normally associated with aging.  A further assumption made was that a 
percentage of the decline in lung volumes and pulmonary functions normally associated 
with aging might be attributed to the deconditioning that usually occurs with aging and 
not completely and solely related to aging alone.  Hagberg et al. (1988) hypothesized 
from their results and the results of other studies that the improvement of pulmonary 
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function found in older endurance athletes might be attributed to enhanced respiratory 
muscle function as a result of practicing aerobic exercise.  
Belman and Gaesser (1988) tested twenty-five elderly subjects, ages 65-75 years, 
to determine if declining pulmonary function impaired exercise capacity.   Subjects were 
tested for exercise capacity and ventilatory muscle endurance before and after an eight-
week training period. Training consisted of isocapnic hyperpnea exercise done 30 
minutes per day and four times per week for eight weeks.  The trained group showed a 
significant increase (p< 0.01) in maximal sustained ventilatory capacity (MSVC).  The 
MSVC for the trained group improved from 71.9 ±  26.4 to 86.9 ±  20.9 liters per minute 
whereas the control group (no training) showed no change (66.3 ±  22.5 to 65.1 ±  22.1 
liters per minute).  The trained group also showed a significant increase (p< 0.01) in 
maximal voluntary ventilation (MVV) from 115 to 135 liters per minute. It was noted 
that there was no increase in either group for maximum O2 uptake, maximum CO2 uptake, 
or MVV during the incremental exercise test. A possible explanation was the subjects 
training was limited to lung exercise and did not involve any walking or running that 
would have improved their leg strength and endurance and resulted in higher VO2max 
scores.   
Cordain, Glisan, Latin, Tucker, and Stager (1987) conducted a study of 101 male 
runners ranging in ages from 16 to 58 years of age.  The purpose of the study was to 
investigate the long-term effects of running upon pulmonary function. Maximal 
inspiratory and expiratory pressures, pulmonary volumes and capacities and 
anthropometric parameters were measured. The results showed no significant difference 
(p < 0.05) in mean PE max for age, suggesting that expiratory muscle strength did not 
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decline significantly after maturity in runners. However mean PI max showed a significant 
trend  (p < 0.001) for declining with age.  No significant trend (p < 0.05) was found for 
decline in FVC related to age except for in the 50-59 year age group. Six different 
prediction equations were used to compare against observed values. Comparison with 
five of the six equations resulted in significantly larger (p< 0.05) FVC values for the 
runners. It was noteworthy that the predicted FVC value from Morris et al. (1971) yielded 
similar results as the measured values. The Morris et al. (1971) study was conducted with 
a large number of subjects and excluded all smokers.  Morris etal. (1971) concluded that 
while running probably does not cause increases in FVC it appeared to have some effect 
in slowing the decline normally seen associated with aging.  
In contrast to the studies that have shown positive correlations to aerobic exercise 
and lung function, McClaran, Babcock, Pegelow, Reddan, and Dempsey (1995) 
conducted a longitudinal study over six years that examined the pulmonary functions of 
18 older adult subjects (ages 67 to 73 years).  McClaran et al. questioned the results of 
studies that showed improved and superior lung function in older athletes. They reasoned 
that since there was no evidence to support that long-term aerobic training had any 
significant beneficial effects upon the pulmonary function of young adults why would 
one expect to find a different result for older athletes.   They concluded from their 
findings that habitual physical activity and high aerobic capacity did not modify the 
normal deterioration of pulmonary lung volume and function associated with aging either 
at rest or during exercise.  During the six-year period TLC, FRC and diffusion capacity 
(DLCO) did not change, but FVC (-11%), FEV1 (-13%), maximal volitional flow rates (-
13%) decreased while RV (+13%) and closing capacity/TLC% (+13%)increased. The 
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results also showed these values were greater than what would be predicted from cross-
sectional norms. This study retested 18 subjects 6 years after initial testing. The subjects 
mean age increased from 67.0 ±  1.2 to 72.9 ±  1.3 years between tests. Ten of the 
eighteen subjects swam, biked, walked, or ran on average of three times per week. The 
other eight subjects were competitive masters runners. A significant positive correlation 
was found between the subjects age and the magnitude of change in RV, DLCO and 
FEV1 (r = 0.48-0.61, P<0.05) showing the older the age at the beginning and end of the 
study the greater the reduction in resting lung function over the six year study.  It was not 
stated but it would have been of informative value to know if the results were different 
between the master runners and the rest of the subjects. The small sample size (18), large 
variance in age (62 to 82 years) and variety of physical activity (walkers to master 
runners) limits the interpretation of the findings.  One possible reason for the conflicting 
findings between the Hagberg et al. (1988) and the McClaran et al. (1995) was the use of 
two different types of study designs. The Hagberg study was cross-sectional while the 
McClaran study was longitudinal.  Another possible explanation could be the difference 
in age between the two groups.  The mean age of the older athletes were 65 ±  3 for the 
Hagberg study and 72.9 ±  1.3 for the McClaran study.          
Chen et al. (1989) investigated the relationship between respiratory muscle 
function and age, sex and other factors. Their study involved 160 subjects comprised of 
men, women, smokers, non-smokers, and both young and old subjects.  The results 
showed inspiratory muscle strength was greater in physically active men then in 
sedentary controls and also that respiratory muscle and pulmonary function decreased 
with age.       
  
 
17 
 
 
 
 
A summary table of the relevant literature can be found in Table 1. As indicated, 
very few investigators have studied the pulmonary function of older endurance athletes 
and the majority were either case studies or of small sample size. The few studies that 
were published that had reasonable a number of subjects have resulted in conflicting 
results. Further investigation can help in answering the question does long term 
participation in aerobic exercise have any protective ability in slowing the decline of 
pulmonary functions normally associated with aging? 
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Table 1. Summary of Research Examining Pulmonary Function of Adults  
 
 
Note: MR =male runner, MS = male sedentary for Yerg, Hagberg and Eastwood.  Selected age group data extracted from Cordain, 
Hagberg, Chen, Babb, and Amara. 
 
Source 
 
Gender N Age BW Ht BMI FVC FEV1 NIF PEF MVV PEF VC VO2 
      (yr) (kg) (m) (BW/Ht
2) (liters) (liters) (cmH2O) (cmH2O) (l/min) (l/min) (liters) (ml/kg/min)
Yerg MR 14 63.0 67.9 1.72 23.0 --- --- --- --- 163.1       ---       --- 52.1 
(1985) MS 14 63.0 83.2 1.76 26.9        ---        ---       ---       --- 143.5       ---       --- 27.6 
Cordain M 25 34.0 73.1 1.75 23.9 5.36       --- 122 202       ---       ---       ---       --- 
(1987) M 8 55.0 77.9 1.78 24.6 4.68       --- 111 178       ---       ---       ---       --- 
Hagberg MR 10
 
65.0 64.5 1.71 22.1 --- 3.52 --- ---  150 --- 4.88 50.0 
(1988) MS 10 66.0 85.7 1.83 25.6  --- 3.49 --- --- 
 
153
 
--- 4.74     27.0 
Chen M 20 34.4 62.8 1.65 23.1       ---       --- 116.5 136.6       ---      ---       ---       --- 
(1989) M 20 53.9 62.8 1.65 23.1       ---       --- 92.8 133.6       ---      ---       ---       --- 
McClaran M, F 30 67.0 65.2 1.71 22.3       --- 3.18       ---      --- 127.2 9.32 4.16 45.3 
(1995) M, F 18 72.9 65.5 1.7 22.7       --- 2.78       ---      --- 111.1 8.04 3.72 40.3 
Babb M 7 38.3 81.8 1.79 25.5 5.54 4.37       ---      --- 194 10.8       ---      --- 
(2000) M 10 54.0 90.2 1.78 28.5 5.06 4.04       ---      --- 168 10.1       ---      --- 
Amara                                                     
(2000) M 181 70.4 77.7 1.73 26.0 --- 2.55       ---       ---       ---       ---       ---       --- 
Eastwood MR 6 37.5 70.8 1.75 23.1 5.8 4.7       ---      ---       ---      ---       --- 58.5 
(2001) MS 6 28.0 91.8 1.80 28.3 5.4 4.4       ---      ---       ---      ---       --- 38.6 
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METHODS 
 
This section consists of detailed descriptions of the subject selection, data collection 
methods, and data analysis.  Spirometery was used to compare the pulmonary function of older 
endurance trained aerobic athletes with that of age-matched non-aerobic exercising controls. All 
subjects were measured for height and weight with BMIs calculated. Spirometery tests included 
measurement of FVC, FEV1, FEF25-75, and PEF. MVV, negative inspiratory force and positive 
expiratory force were also measured. Statistical analysis was used to determine if significant 
differences in pulmonary function exist between the athletes and the controls. 
Subjects 
 
The study collected and compared the pulmonary function data of two groups of 
individuals.  All subjects participating in the study were apparently healthy, adult males between 
the ages of 45 and 65. They were non-smokers of tobacco without any history of pulmonary 
diseases such as asthma or emphysema. The test subjects were men who have exercised regularly 
by jogging or running most of their adult lives. The control subjects were men of the same age 
who had not exercised regularly, particularly by jogging or running, most of their adult lives. 
Twenty subjects comprised each group. Since the study only involved non-invasive, non-
strenuous pulmonary function testing, medical approval by the subjects physician was not 
required.  Approval for the study was obtained from the University of New Orleanss Committee 
for the Use of Human Subjects (see Appendix A).  Written informed consent was obtained from 
all subjects after they were informed of the possible dangers and purpose of the study (see 
Appendix B). The test subjects were Caucasian male adults ranging in age from 45 to 65 years of 
age. They were runners who have run consistently for at least the last 10 years and averaged a 
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minimum of at least 20 miles per week during the last calendar year. Self-report was used to 
establish the subjects running history. Exercise subjects were recruited from the New Orleans 
Track Club, Cajun Road Runners, and other local area runners. An explanatory letter, and a 
qualifying questionnaire along with a self-addressed postage paid return envelope was handed 
out or mailed to all potential study participants. 
The control subjects were Caucasian male adults ranging from 45 to 65 years of age. 
Controls were age-matched and recruited from the general population. An extended history of 
any type of aerobic exercise including but not limited to cycling, swimming, cross-country 
skiing, rowing, in-line skating, jumping rope, bench-stepping, stair climbing or running was used 
to exclude subjects from the study.  Potential control subjects were recruited from local area 
softball and bowling leagues as well as local area social organizations.    
Testing was begun once a subject had been identified and qualified. An activity 
questionnaire was used to assess general health and activity level (see Appendix C). Each subject 
was scheduled for a single testing session that lasted no more than 30 minutes. Anthropomorphic 
measurements of height and weight were taken and recorded.  
Measures 
Each subjects weight was measured with a Healthometer model HAP400 professional 
dial scale that was calibrated with a standard 10-kilogram weight before each session. Weights 
were recorded in kilograms to the nearest 0.1-kilogram.  Subjects were required to stand on the 
scale with their weight evenly distributed between both feet and with arms hanging freely at their 
sides.  Two measurements of weight were taken for each subject and if the measurements varied 
by more than 0.1 kilogram the measurements were repeated until the standard was met. 
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Height was measured using a Secca model 214 Road Rod portable stadiometer. 
Subjects were required to stand erect with their weight distributed evenly between both feet, 
arms hanging freely at their sides, and palms facing the thighs.  Subjects were required to place 
ankles and or knees together so that they touch one another if possible. The subjects head was 
then placed in the Frankfurt Horizontal plane and then were asked to inhale to full lung capacity 
without altering their stance.  The headboard was then lowered with enough pressure to 
compress the subjects hair and make contact with the most superior part of the head. The 
measurements were recorded in centimeters to the nearest 0.1-centimeter.  Two measurements of 
height were taken for each subject and if the measurements varied by more than 0.1 centimeter 
the measurements were repeated until the standard was met. 
Body mass index was calculated with the collected height and weight measurements 
using the standard formula of BMI = body mass (weight in kilograms) divided by stature (height 
in meters squared) or (BMI = kg/m2).  
Pulmonary Function Tests 
Each pulmonary function test was fully explained and demonstrated to each test subject. 
Once the subject acknowledged understanding of the procedure they were allowed two practice 
maneuvers before recording of test results began.  Only pulmonary function test results that met 
all requirements set forth by the American Thoracic Society (1987) were accepted and included 
as test data. The following specific pulmonary tests were conducted upon each subject. 
Maximum inspiratory and expiratory pressures (MIP, MEP), flow-volume loops, and maximum 
voluntary ventilation (MVV) comprised the three pulmonary function tests that were performed 
upon each subject. 
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Negative inspiratory force (NIF) and positive expiratory force (PEF) were measured using a 
Technika Scientific Equipment Model 840080 manometer. To measure the PEF the subject was 
instructed to inhale completely to total lung capacity and then exhale as forcefully as possible 
into the pressure gauge.   Each test was performed 3 times. The test that resulted in the greatest 
value and was also held for a minimum of 1 second was taken and recorded as the subjects PEF 
and was recorded in positive centimeters of water (cmH2O).  NIF was obtained by having the 
subject first exhale completely to residual volume followed by inhaling as forcefully as possible. 
The test that resulted in the greatest value and was also held for a minimum of 1 second was 
taken and recorded as the subjects NIF and was recorded in negative centimeters of water 
(cmH2O). 
Flow-Volume Loops were measured with a Puritan Bennet Renaissance II portable 
spirometery system. The Renaissance spirometer was calibrated before testing began on each 
subject and performed in accordance with both the manufacturers and the American Thoracic 
Societys (1987) guidelines. Forced vital capacity (FVC), forced expiratory capacity one 
second (FEV1), forced expiratory mid-flow (FEF25%-75%), and peak expiratory flow (PEF) were 
the pulmonary function values that were measured and recorded from the flow-volume loop 
tests.  The subject was required to stand erect and wear a nose clip for each flow-volume test. 
They were instructed to place the mouthpiece fully into their mouth so the end of the 
mouthpiece was at least 1 inch beyond the exterior of their lips and to form as tight a seal as 
possible by keeping their mouth closed and exerting moderate force with their lips around the 
mouthpiece. The subject then took 3 to5 easy resting breaths before being instructed to inhale 
quickly to maximal lung capacity followed by immediately exhaling with maximum force for 
at least six seconds and ending with a final inhalation back to maximal lung capacity. In 
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accordance with the standards and guidelines set forth by the ATS regarding acceptable results 
for flow-volume loops each subject performed a minimum of 3 trials. However, each subject 
was allowed as many trials as necessary to obtain 2 trials that had results that were within 10% 
of one another and also met all other criteria. Flow-volume loop parameters were measured and 
reported in liters and liters per second at BTPS.  
Maximal Voluntary Ventilation was measured with a Puritan Bennet Renaissance II 
portable spirometery system. The Renaissance spirometer was calibrated before testing began 
on each subject and performed in accordance with both the manufacturers and the American 
Thoracic Societys guidelines.  The subject was required to stand erect and wear a nose clip for 
each flow-volume test. They were instructed to place the spirometery mouthpiece fully into 
their mouths so the end of the mouthpiece was at least 1 inch beyond the exterior of their lips 
and to form as tight a seal as possible by keeping their mouths closed and exerting moderate 
force with their lips around the mouthpiece. The subject then took 3 to5 easy resting breaths 
before being instructed to begin breathing as deeply and quickly as possible for 12 seconds. 
The subjects were advised to avoid extremes of either frequency or tidal volumes since neither 
panting nor slow deep breathing leads to the greatest possible test values. MVV were repeated 
at least twice but no more than three times.  Three minutes rest was given between trials to 
prevent fatigue that might have a negative effect upon performance.  MVV results were 
measured and reported in liters per minute at BTPS.   
Statistical Analysis 
SPSS version 11.0 for Windows was used for statistical analysis. All data were reported 
as means and standard deviations.  An alpha level of 0.05 was used to determine statistical 
significance. Correlational analysis was used to assess relationships of all continuous variables in 
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the study.  Analysis of variance (ANOVA) was used to determine differences in age, height, 
weight, BMI, and respiratory muscle force between groups. Multivariable analysis of variance 
(MANOVA) was used to investigate differences in forced vital capacity, forces expiratory 
volume one second, forced expiratory flow 25-75%, peak expiratory flow, and maximum 
voluntary ventilation between runners and non-runners and runners and population norms.   
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RESULTS 
 
 
This study proposed two hypotheses. The first hypothesis was that older runners would 
have significantly greater (p < 0.05) pulmonary lung function than aged-matched nonrunners. 
The second hypothesis was that the runners would have significantly greater pulmonary function 
values than the population norms when matched for age, height, sex, and race as predicted by 
Knudson et al. (1983) pulmonary function prediction equations.  
A subject data table (see Appendix F) and complete correlation matrix of all variables 
using Pearson product correlation coefficients can be found in Appendix G. There were 40 male 
Caucasian subjects (N = 40, 20 Runners, 20 Nonrunners).  The strongest correlations were found 
between height and weight (0.61), weight and BMI (0.92), FVC and FEV1 (0.79), and FEV1 and 
FEF25-75 (0.71).  Moderate correlations were found between NIF and PEF (0.44), height and FVC 
(0.50), height and FEV1 (0.45), height and %FVC (-0.59), weight and %FVC (-0.53), height and 
% FEV1 (-0.54), weight and % FEV1 (-0.43), MVV and FVC (0.41), MVV and FEV1 (0.57) and 
MVV and PeakFlow (0.53). 
ANOVA analysis of respiratory muscle strength between groups was not significant for 
either NIF or PEF.  The NIF was 118 ±  24.2 cmH2O for the runners and 117 ±  53.1 cmH2O for 
the nonrunners with F = 0.006 and p = 0.939.  The PEF was 144 ±  55.3 cmH2O for the runners 
and 142.4 ±  56.6 cmH2O for the nonrunners with F = 0.008 and p = 0.931.  
Table 2 lists the mean, standard deviation (SD), F value, and the p from ANOVA analysis 
of the physical characteristics of age, height, weight, and BMI for runners and non-runners.  The 
mean age for the runners was 56.0 yrs. and 52.8 yrs. for the non-runners with F = 3.252 and p = 
0.079 between the two groups.  The mean height for the runners was 175.6 cm and 178.3 cm for 
 26 
 
 
 
 
 
         RUNNERS     NON-RUNNERS
Mean SD Mean SD F p
Age (yrs) 56.0 6.6 52.8 4.5 3.252 .079
 
Height (cm) 175.6 7.4 178.3 6.1 1.530 .224
Weight (kg) 77.5 10.6 94.1 17.1 13.640 .001*
  
BMI 25.1 2.4 29.5 4.2 16.530 .000*
the non-runners with F = 1.530 and p = 0.224.   The mean weight for the runners was 77.5 kg 
and 94.1 kg for the non-runners with F = 13.640 and p = 0.001.  The mean BMI for the runners 
was 25.1 and 29.5 for the non-runners with F = 16.530 and p = 0.001. 
 
Table 2. Physical Characteristics of Subjects 
 
 
 
 
 
 
 
 
 
 
 
*p<0.05 
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     RUNNERS   NON-RUNNERS 
        N = 20        N = 20
MEAN SD MEAN SD F p Eta Squared
FVC 5.2 0.7 5.0 0.5 0.939 0.339 0.024
FEV1 3.9 0.7 3.8 0.4 0.221 0.641 0.006
FEV25-75% 3.1 1.1 3.3 0.9 0.423 0.519 0.011
PEF 9.2 1.5 8.9 1.6 0.411 0.525 0.011
MVV 159.9 23.5 144.9 20.8 4.576 0.039 0.107
A MANOVA was computed to assess differences between runners and non-runners on 
the absolute pulmonary function variables of forced vital capacity (FVC), forced expiratory 
volume one second (FEV1), forced expiratory flow 25-75% ( FEF25-75%), peak expiratory flow 
(PEF), and maximum voluntary ventilation (MVV).   The results of the MANOVA (Wilks λ = 
.839, F = [1,38] = 1.306, p = .285) indicated that there was no significant difference between the 
two groups. The results are shown in table 3.  
 
Table 3. MANOVA Results of Absolute Pulmonary Function           
                  Variables between Runners and Non-Runners.               
 
 
  
 
 
 
 
 
 
*p< 0.05 
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     RUNNERS   NON-RUNNERS 
        N = 20        N = 20
MEAN SD MEAN SD F p Eta Squared
%FVC 120.6 15.1 108.2 11.5 8.572 0.006* 0.184
%FEV1 111.1 16.9 100.8 8.9 5.694 0.022* 0.131
 
%FEV25-75% 87.2 26.8 83 22.9 0.284 0.597 0.007
 
%PEF 105.9 18.8 99.4 15.8 1.407 0.243 0.033
%MVV 125.9 18.4 110.7 14.8 8.253 0.007* 0.178
 Another MANOVA was used to examine differences in pulmonary function as a percent 
of predicted (Knudsons 1983) between runners and nonrunners for the variables of forced vital 
capacity (FVC), forced expiratory volume one second (FEV1), forced expiratory flow 25-75% 
(FEF25-75%), peak expiratory flow (PEF), and maximum voluntary ventilation (MVV). The results 
of the MANOVA (Wilks λ = .839, F = [1,38] = 2.877, p = .029) indicated a significant 
difference between the two groups. Three of the five measured variables returned significant 
differences. The runners (N = 20) had significantly greater forced vital capacity (M = 120.6, SD 
= 15.1 vs. M = 108.2, SD =11.5, p =. 006), significantly greater forced expiratory volume one 
second (M = 111.1, SD = 16.9 vs. M = 100.8, SD =8.9, p =. 022), and significantly greater 
maximum voluntary ventilation (M = 125.9, SD = 18.4 vs. M = 110.7, SD =14.8, p =. 007) than 
the non-runners (N = 20), (p = .029).   Results are shown in Table 4 and bar graphs of the results 
can be found in appendix H.     
Table 4. MANOVA Results of Predicted Pulmonary Function 
Variables between Runners and Non-Runners. 
 
 
 
 
 
 
 
 
*p< 0.05 
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     RUNNERS   NON-RUNNERS 
        N  = 20        N = 20
MEAN SD MEAN SD F p Eta Squared
FVC 5.20 0.70 4.30 0.67 14.583 0.001* 0.277
FEV1 3.90 0.65 3.50 0.55 3.564 0.067 0.086
FEV25-75% 3.10 1.05 3.59 0.52 3.494 0.069 0.084
PEF 9.20 1.49 8.51 0.76 3.297 0.077 0.080
MVV 159.90 23.50 125.20 11.00 35.598 0.001* 0.484
A third MANOVA was used to examine differences in the measured pulmonary function 
variables of the runners compared to population norms as predicted by Knudsons (1983) 
prediction equations. The measured variables were (FVC), forced expiratory volume one second 
(FEV1), forced expiratory flow 25-75% (FEF25-75%), peak expiratory flow (PEF), and maximum 
voluntary ventilation (MVV). The runners measured absolute values were compared to their 
predicted values with the predicted values representing the population norms. Subjects were 
matched for age, height, weight, race, and sex. The results of the MANOVA (Wilks λ = .304, F 
= [1,38] = 15.559, p = .001) indicated that there was a significant difference between the two 
groups. Two of the five variables were significantly different. Specifically, the runners had 
greater forced vital capacity (M = 5.19, SD = 0.739 vs. M = 4.34, SD = 0.674, p =. 001), and 
greater maximum voluntary ventilation (M = 159.9, SD = 23.5 vs. M = 125.2, SD = 11.0, p =. 
001) than the general population. Results are shown in table 5.      
Table 5. MANOVA Results of Predicted Pulmonary Function 
       Variables between Runners and Population Norms. 
 
 
 
 
 
 
*p < 0.05 
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The following five figures are bar graphs that represent the difference in chronological 
age versus calculated lung age for runners and non-runners. The calculated lung age represents 
the hypothetical age of the persons lung based upon each absolute pulmonary function 
measurement (FVC, FEV1, FEF25-75%, PEF, or MVV), height, race, and sex. The calculated lung 
age was derived at by using the Knudson (1983) pulmonary function prediction equation and 
solving for age once the measured pulmonary function value was known.  Figures 1- 5 show the 
calculated average lung age for runners and nonrunners for FVC, FEV1, FEF25-75%, PEF, and 
MVV.   
Figure 1. Calculated Lung Age vs Chronological Age (FVC) 
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Figure 2. Calculated Lung Age vs Chronological Age (FEV1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Calculated Lung Age vs Chronological Age (FEF25-75) 
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Figure 4. Calculated Lung Age vs Chronological Age (PEF) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Calculated Lung Age vs Chronological Age (MVV) 
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DISCUSSION 
 
 
The decline of pulmonary function associated with aging in the general population has 
been thoroughly investigated and repeatedly supported in the research literature.  Knudson et al. 
(1977) conducted a study on the relationship between aging and decline in pulmonary function 
and concluded that there was a loss of total lung capacity related to aging. They also concluded 
that the declines were related to a loss of elastic recoil of the lungs. Studies by Dempsey and 
Seals (1995), Delorey et al. (1999), and Babb et al. (2000) all indicated similar findings relating 
decreases in pulmonary function to aging.   
The idea that continued aerobic exercise slows the decline of pulmonary function 
normally associated with aging has not been researched as widely as that of the decline of 
pulmonary function and aging in the general population. Furthermore the existing literature 
presents confounding and therefore inconclusive results.  For example, Hagberg et al. (1988) 
hypothesized from their results and the results of other studies that the improvement of 
pulmonary function found in older endurance athletes might be attributed to enhanced respiratory 
muscle function as a result of practicing aerobic exercise.  The results of the current study do not 
support the idea that enhanced respiratory muscle function is the explanation for improved 
pulmonary function. The current study found significantly greater pulmonary function in the 
runners but no difference in respiratory muscle strength between the two groups.  McClaran et al. 
(1995) concluded that habitual physical activity and high aerobic capacity did not modify the 
normal deterioration of pulmonary lung volume and function associated with aging either at rest 
or during exercise. The current study found pulmonary function values for the runners that 
compared to significantly younger individuals suggesting that habitual physical activity and high 
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aerobic capacity might modify the normal deterioration of pulmonary lung volume and function 
associated with aging.    
The current study examined the relationship between the pulmonary function of older 
male subjects (N = 20, M = 56.0, SD  = 6.6) who exercised regularly by running with that of age-
matched non-aerobic exercising controls  (N = 20, M = 52.8, SD  = 4.5).  The study also 
examined the relationship of pulmonary function between runners and the population norms. The 
population norms were represented by using the predicted values of the runners as calculated by 
the Knudson et al. (1983) equations.  Two hypotheses were proposed.  The first stated that the 
runners would have greater pulmonary function values than the non-runners.   The second 
hypothesis stated that the runners would have significantly greater (p < 0.05) pulmonary function 
values than the population norms when matched for age, height, sex, and race as predicted by 
Knudson et al. (1983) pulmonary function prediction equations. The Puritan-Bennett 
Renaissance II portable spirometer was used to collect pulmonary flow-volume measurements. 
The Technika Scientific Equipment Model 840080 manometer was used to measure maximum 
negative inspiratory force and positive expiratory force.    
Comparison of respiratory muscle strength was assessed by measurement of maximum 
inspiratory and expiratory forces.  Results from an ANOVA test showed no significant difference 
between groups (p < 0.05) for maximum inspiratory force. The runners values were (M = 118.0, 
SD = 24.2 cmH2O) and the non-runners values were (M = 117.0, SD = 53.2 cmH2O).  There was 
also no significant difference found between groups  (p < 0.05) for maximum expiratory force. 
The runners values were (M = 144 SD = 55.3 cmH2O) and the non-runners values were (M = 
142, SD = 56.6 cmH2O).  These findings were different then those of Chen et al. (1989) who 
found the average value for a group of 20 male subjects aged (M = 53.9, SD = 0.7) to be (M = 
 35 
 
 
 
 
 
92.8, SD = 4.3 cmH2O) for maximum inspiratory force and (M =133.6, SD = 9.0 cmH2O) for 
maximum expiratory force.  The higher values for the current study  (NIF, 117 versus 93) and 
(PEF, 144 versus 133) may be explained by the fact that the subjects in the current study were 
taller (177.0 cm versus 165.1 cm) and heavier (85.9 kg versus 62.8 kg) then those tested by Chen 
et al. (1989).  Maximum inspiratory pressure in the current study (118 ±  24 cmH2O) also 
matched very closely with that of a similar study of male runners (111 ±  25 cmH2O) (Cordain 
et al., 1987).  A rather large difference in maximum expiratory pressure existed between the 
current study (144 ±  55 cmH2O) and that of Cordain et al. (1987) (178 ±  46 cmH2O). A 
possible explanation for the discrepancy may have been due to the difficulty of maintaining a 
tight mouth seal that prevents leaks while measuring maximum expiratory pressures. It is 
possible that Cordain et al., (1987) had a better mechanical arrangement for performing this test.  
The results of this study on respiratory muscle strength agree with the findings of Eastwood, 
Hillman and Finucane (2001) that concluded that respiratory muscle strength was not different 
between sedentary subjects and highly trained marathon runners. It would seem from the results 
of this study and similar studies that aerobic exercise in the form of running does not increase 
respiratory muscle strength when measured as either maximum inspiratory or expiratory force 
and therefore cannot be used to explain the greater pulmonary function of the runners. 
 Pulmonary function was measured using the Puritan-Bennett Renaissance II portable 
spirometer. Flow-volume loop spirometery was performed on all subjects and the guidelines set 
forth by the American Thoracic Society (1987) for pulmonary functions were followed.   Forced 
vital capacity (FVC), forced expiratory volume one second (FEV1), forced expiratory flow 25-
75% ( FEF25-75%), peak expiratory flow (PEF), and maximum voluntary ventilation (MVV) were 
the measured variables.  All values were recorded as both absolute and percent of predicted using 
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the prediction equations of Knudson et al. (1983).  This method was selected because Knudsons 
equations normalize values based upon sex, race, age, and height.  Since the study sample was 
homogeneous for sex and race using this method presented a more elegant solution for 
accounting for the differences in pulmonary measurements introduced by variations in age and 
height.  A two-way between-groups multivariate analysis of variance (MANOVA) was used to 
investigate differences between runners and non-runners for FVC, FEV1, FEF25-75%, PEF, and 
MVV.  No significant difference was found between groups when compared as absolute 
measured values.  Although there was not a statistically significant difference in either height nor 
age between the two groups, the non-runners who were slightly younger (53 vs 56 yrs) and also 
slightly taller (178 vs 176 cm) should have had larger absolute values according to all pulmonary 
function prediction equations.  This was not the case; the runners had larger absolute values for 
all measured pulmonary function variables in spite of the fact that they were older and shorter.  
When the two groups were adjusted for height and age using the Knudson prediction 
equations a significant difference between groups (p < 0.05) was found that indicated the 
runners group had greater pulmonary function.   The runners had greater values for FVC 
(120.6% versus 108.2%), FEV1 (111.1% versus 100.8%), MVV (125.9% versus 110.7%) that 
resulted in a MANOVA value of (p = 0.029). PEF was not statistically significant (p= 0.243) but 
resulted in a greater value for the runners (105.9% versus 99.4%).  FEF25-75% was the only 
pulmonary function variable that showed no appreciable difference between groups (p = 0.597) 
with average values of 87.2% for the runners and 83.0% for the non-runners.   
The results of this study suggest that men aged 45-65 who have run for at least the last 
ten years have greater pulmonary function then age-matched non-aerobic exercising controls.  
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These results agree with previous research by Yerg et al. (1985), Hagberg et al. (1988), Amara et 
al. (2000), and Cheng, Macera, Addy, Sy, Wieland and Blair (2003).   
A study on the effect of endurance training on the ventilatory function in older 
individuals by Yerg et al. (1985) found that prolonged endurance training in previously sedentary 
subjects resulted in significant positive changes.  The only pulmonary function measure that this 
study had in common with the current study was that of MVV.  The master athletes in the Yerg 
study had an average MVV of 163 liters per minute and the runners in the current study had an 
average MVV of 159 liters per minute.  The sedentary subjects in Yergs study had an average 
MVV of 143 liters per minute and the non-runners in the current study had an average MVV of 
144 liters per minute. The Yerg study not only compared master athletes to sedentary subjects 
but also performed a longitudinal study that trained sedentary subjects for 12 months. Training 
consisted of low-intensity walking for the first six months followed by higher intensity activities 
such as cycling, jogging, and graded treadmill walking at 75-85% of heart rate reserve.   
Although a 25% increase in VO2 max was achieved after training there was no increase in MVV 
shown after 1 year of training.  There was a significant increase (p <0.005) in VEmax and the 
percent of MVV used at VEmax after training.   The authors concluded that prolonged endurance 
training in older previously sedentary individuals resulted in a significant reduction in the level 
of ventilation required to perform a given amount of work and this indicated an adaptation to 
exercise rather than an inherent characteristic of endurance athletes.  The inability of the subjects 
in the Yerg (1985) longitudinal study to increase their MVV may have been related to the 
intensity and duration of the training program. They trained far less intensively and for a far 
shorter time then the master athletes.  It is possible that had they trained longer and harder that 
increases in their MVV might have occurred.  The authors concluded that older sedentary 
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individuals could achieve the same efficient level of ventilation during submaximal exercise and 
also utilize the same percent on MVV during maximal exercise as a trained athlete.    
Amara et al. (2001) reported that physical activity provided a small but significant 
contribution to greater FEV1 in active individuals.  They also found that fat free mass (FFM) 
was the strongest predicator of FEV1. They indicated as the ratio of FFM to total mass (TM) 
increased so did the subjects FEV1s suggesting greater FEV1s for leaner individuals. 
Although the present study calculated BMI and not FFM it is reasonable to assume that lower 
BMIs should result in leaner body mass. The exception to this assumption would be if body 
builders were included but since they were not, the results of the current study agree with Amara 
et al. (2001). The average BMI of the runners in the present study was 25.1 compared to 29.5 for 
the non-runners with the runners having significantly greater FEV1s (111.1% versus 100.8%) 
then the non-runners.  Amara et al. (2001) concluded that physical activity and body composition 
might be more important factors in determining forced expiratory function than previously 
recognized.  
Hagberg et al. (1988) found that a group of older athletes had 119 ±  18% of their 
predicted vital capacity compared to 99 ±  10% predicted for older sedentary subjects.  These 
values compared favorably with the results from the current study, especially for the runners who 
had vital capacities of 121 ± 15% while the non-runners measured at 108 ± 12% of predicted.  
The FEV1 for the older athletes in Hagbergs study had 123 ± 15% predicted versus 107 ± 15% 
predicted for the sedentary controls. This compared to 111 ± 17% predicted for the older runners 
and 101 ± 9% predicted for the non-runners in the current study.  Although the FEV1 values from 
the two studies are not as close as those for vital capacity they both show a significant difference 
with the athletes/runners having greater pulmonary function measures then the non-athletes. 
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Maximum voluntary ventilation (MVV) was also tested in both studies with similar results. The 
older athletes in the Hagberg study had values of 119 ± 18% that compared to 125 ± 18% for 
runners in the current study.  The older non-athletes in the Hagberg study had values of 108 
± 17% compared to 111 ± 15% for the non-runners in the current study.  The Hagberg study 
included not only older athletes and sedentary controls but also young athletes and sedentaries. 
They found no difference when they compared the pulmonary function of the young athletes 
with that of the young untrained men. They did find a significant difference between the 
pulmonary function of the older athletes and the older sedentaries. They also found the older 
athletes were the only group that had lung volumes and pulmonary function values that were 
substantially greater than predicted. Hagberg et al. (1988) concluded that the older athletes 
appeared to have slowed or lessened the age-related decline of pulmonary function normally 
found in the general population through the practice of continued strenuous endurance exercise.    
The results of the current study agree with the findings made by Hagberg et al. and further 
support the idea that aerobic exercise is related to greater than predicted pulmonary function in 
older men. 
The results of the current study were also in agreement with the findings of Cheng et al. 
(2003). This was a large study that was both cross-sectional and longitudinal in design.  The 
cross sectional portion included 24,536 healthy subjects and the longitudinal study lasted five 
years and included 5,707 subjects.  The purpose of this dual design study was to compare the 
role of respiratory function on the association of change in physical activity habits and also the 
changes that occur over time in healthy individuals.  The cross-sectional study results indicated 
that the men in the highest activity group had average FVC values of 5.14 liters compared to 
4.87 for the sedentary group and average FEV1 values of 4.02 liters compared to 3.79 liters for 
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the sedentary. The average FVC in the current study was 5.19 liters for the runners and 4.99 
liters for the non-runners and the average FEV1 was 3.86 liters for the runners and 3.78 liters for 
the non-runners.  The activity levels were very similar in both studies. Cheng defined high 
activity as running at least 20 miles per week and the average of the runners in the current study 
was 24 miles per week.  
The longitudinal results of the Cheng et al. showed that men who remained active over 
the five-year study period were the only group that improved or maintained their FVC and FEV1 
values. Cheng et al. (2003) concluded that physical activity was important in maintaining both 
cardiovascular and respiratory function.  
A seven-year longitudinal study by McClaran et al. (1995) found no evidence that 
physical activity slowed the decline of pulmonary function associated with aging in active older 
subjects. Average group vital capacity declined from 4.16 liters to 3.72 liters and FEV1 declined 
from 3.18 liters to 2.78 liters over a seven-year period. McClaran et al. (1995) concluded that 
habitual physical activity and aerobic exercise did not modify the normal deterioration of 
pulmonary function associated with aging. A possible reason for the discrepancy in findings 
between this study and others such as Hagberg et al. (1988) may be explained by the fact that the 
subjects in the McClaran study were older with an average age of 72.9 years and a range from 62 
to 82.   The average age of the runners in the current study was 56.0 years with a range from 46 
to 65. The average age of the older athletes in the Hagberg study was 65 and the average age of 
the male subjects in the Cheng study was 40.9 years with a range from 25 to 55.  If conclusions 
of McClaran et al. (1995) are correct then it is possible that the protective benefits of aerobic 
exercise on pulmonary function becomes less effective with age. It is also possible that other 
factors associated with aging, such as muscular, skeletal, joint, and or cardiac problems might 
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prevent the older subjects from exercising at a sufficient intensity to maintain the benefits to 
pulmonary function seen in the younger subjects. 
The calculated lung age versus chronological calculations and bar graphs combined the 
results of the runners and non-runners and that of the runners and population norms into one 
picture. Each figure with the exception of FEF25-75 clearly showed that the runners had greater 
pulmonary function values than both the non-runners and the population norms.   
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CONCLUSION 
 
The findings from the current study supported both proposed hypotheses. The results 
supported the hypothesis that older runners would have greater pulmonary function than older 
non-runners. A significant difference (p < 0.05) for pulmonary function was found between older 
runners and older non-runners.  The non-runners were screened to exclude for any types of 
aerobic exercise other than casual walking.  Activity level, either runner or non-runner, was the 
independent variable and forced vital capacity (FVC), forced expiratory volume one second 
(FEV1), forced expiratory mid flow (FEF25-75%), peak expiratory flow (PEF), and maximum 
voluntary ventilation (MVV) were the measured dependent variables.  Multivariate analysis 
resulted in a significant difference (p < 0.05 with the runners having greater pulmonary function 
values than the non-runners. Univariate analysis resulted in significant differences for three of 
the five independent variables, FVC, FEV1, and MVV with PEF approaching significance.  
FEF25-75% was the only variable that showed no significant difference between groups.  The fact 
that FEF25-75% was not significantly different between the two groups was not that surprising a 
finding when effort independent nature of a FEF25-75% is considered.  Age and height differences 
were controlled for using the Knudson et al. (1983) pulmonary prediction equations.  Subjects 
were then compared based upon their scores as a percent of predicted.  The results of the current 
study were in close agreement with the results of several similar or related studies.   
In addition to using percent of predicted scores for multivariate analysis calculated lung 
age versus chronological age was also compared.  The Knudson prediction equations for FVC, 
FEV1, FEF25-75%, PEF and MVV were used to solve for age once the subjects actual pulmonary 
function value was known.  The runners calculated lung age was lower than the non-runners in 
every category even though the non-runners were chronologically three years younger than the 
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runners.  The runners had younger predicted lung ages for FVC (M = 37 vs. M = 44), FEV1  (M 
= 45 vs. M = 52), FEF25-75%, (M = 66 vs. M = 70), PEF (M = 49 vs. M = 61), and MVV (M = 32 
vs. M = 42) than the non-runners.   The older runners calculated lung ages were well below their 
actual chronological ages in every category except for FEF25-75%.  Both groups, runners and non-
runners, had calculated lung age scores greater than their actual chronological ages for FEF25-75%.  
FEF25-75% is the one of the best indicators of reduced pulmonary function of small airways seen 
in asthma and reactive type airway diseases. A possible explanation for this finding may be the 
local environment and air quality. Southern Louisiana has a large petro-chemical industry 
contributing to poor air quality combined with air that normally has a high pollen and mold 
count, both factors are know contributors to respiratory diseases. The nature of this question was 
beyond the scope of the present study and only offers a purely speculative explanation.  
Respiratory muscle strength was measured as maximum inspiratory and expiratory force 
generation. There was essentially no difference between the runners and non-runners for either 
measure. Respiratory muscle strength was not considered a measure of pulmonary function but 
as a potential explanation for differences between groups. No significant differences were found 
therefore the author could not conclude that respiratory muscle strength was related to 
pulmonary function.     
The second hypothesis stated that the older runners would have greater pulmonary 
function than the general population as predicted by the Knudson et al. (1983) pulmonary 
function prediction equations.   The results supported the hypothesis that older runners would 
have greater pulmonary function than the general population. A significant difference (p < 0.05) 
for pulmonary function was found between older runners and the general population.  
Multivariate analysis resulted in a significant difference (p < 0.05) with the runners having 
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greater pulmonary function values than the general population. Univariate analysis resulted in 
significant differences for two of the five independent variables. The runners had significantly 
greater values for FVC and MVV than the general population with FEV1 and PEF approaching 
significance.  The FEF25-75% also approached significance however this value was greater for the 
general population then for the older runners.   
In summary, the findings of greater pulmonary function values for the older athletes 
compared to the controls in the current study are generally similar to those found in studies by 
Yerg et al. (1985), Hagberg et al. (1988), and Amara et al. (2001).  The results suggest that high 
levels of physical activity, such as endurance running, may lead to a slower decline in pulmonary 
function then typically seen in the sedentary population.  The findings of greater pulmonary 
function values for the older athletes when compared to the general population would also 
suggest that physical activity might positively enhance pulmonary functions in this age group. 
Opportunities for future study would be to follow the same subjects over time. A 
longitudinal study would yield insightful information on whether or not long-term aerobic 
exercise does in fact slow the decline of pulmonary function that is observed in the normal 
population. Another question raised by this study was why did both the runners and non-runners 
have FEF25-75 values that were below the population norms?  
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APPENDIX B 
 
Participant Consent Form 
 
1. Title of Research Study: Comparison of the pulmonary function of older endurance athletes 
with age-matched sedentary controls. 
 
2. Research Director:  James C. Buras, Graduate Student, 504-488-9366, jcburas@uno.edu 
 
3. Purpose of Research:  The purpose of this research will be to determine if endurance running has a 
positive effect upon the decline of pulmonary function normally associated with aging. 
 
4. Procedures for this Research:  For this study you will be asked to first complete a questionnaire 
regarding your exercise habits and then have your lung function measured. Lung function measurement 
will involve three different tests. The first will measure maximum inspiratory and expiratory force. This 
test requires inhaling and exhaling as hard as possible. The second test employs spirometery to measure 
lung volumes and flows and involves inhaling to your maximum lung capacity and then exhaling 
forcefully and completely. You will be asked to repeat this test several times. The third test measures 
maximum minute ventilation and involves breathing as deeply and quickly as possible for 12 seconds.  
The entire test procedure should not take more than 15 to 20 minutes.  
 
5. Potential Risk of Discomfort:  The potential risks of discomfort are minimal. Fatigue, shortness of 
breath, and or lightheadedness are possible but unlikely complications associated with pulmonary 
function tests.  You will be given as much break time as needed between tests to rest before testing 
resumes.  If you wish to discuss these or any other discomforts that you may experience, you may call the 
Project Director listed in #2 of this form.   
 
6. Potential Benefits to You or Others:  You will be given a copy of your pulmonary function tests with 
values compared to population norms.  The information from this study will help us to better understand 
the relationship between aerobic exercise and aging.  Additionally, upon your request, you may receive a 
summary of the group data from this study from the Project Director.   
 
7. Alternative Procedures:  There are no alternative procedures associated with this study. Your 
participation in this study is entirely voluntary and you may withdraw consent and terminate participation 
at anytime without consequence. 
 
 
 
I have been fully informed of the above-described procedure with its possible benefits and risks and 
I have given permission of participation in this study. 
 
 
 
Signature of Participant             Name of participant (Print)              Date 
 
 
Signature of Person                  Name of Person Obtaining               Date  
Obtaining Consent                   Consent  (Print) 
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APPENDIX C 
 
 Subject Questionnaire 
Jim Buras 504-488-9366/jcburas@uno.edu 
 
      My name is Jim Buras and Im a graduate student at UNO. My masters thesis involves 
examining the relationship between distance-running and pulmonary lung function. The tests 
involved in this study will require approximately 15 to 20 minutes of your time and involve only 
a minimal amount of physical exertion or discomfort. Your participation will be greatly 
appreciated.      
 
NAME ____________________________________ 
 
Telephone # ________________________     Email ______________________ 
 
AGE ___________       HEIGHT __________      WEIGHT __________ 
 
1.  Do you consider yourself to be in relatively good health?  YES   NO  (circle one)   
 
2.  Do you have any heart or lung diseases?  YES   NO  (circle one)   
 
3.  Do you currently smoke cigarettes?  YES   NO  (circle one)   
 
4. If you previously smoked how ago did you stop? _______ 
 
5. Do you participate in any kind of regular exercise routine?  YES   NO  (circle one)   
 
6. Are you a runner?  YES   NO  (circle one) If NO skip to line 12. 
 
7. If yes what is your average miles per week during last 12 months? _________ 
 
8. How many years have you been running? ____________ 
 
9.  At what age did you start running?  ___________ 
 
10.  How many marathons have you run? ____ Date of last marathon________   PR ______ 
 
11. Date of last 10K _______Time for last 10K ________   10K PR ______   5K PR ______  
 
12. Describe your exercise routine if any in detail. (Example: walk 2 miles 3 times a week) 
    
      ______________________________________________________________________ 
 
      ______________________________________________________________________ 
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APPENDIX D 
SPIROMETER CALIBRATION PROCEDURE 
 
 
 
Standard calibration verification of the Puritan-Bennett Renaissance II spirometer will be 
performed before testing of each subject in order to verify the accuracy of the system.  The 
ATS recommends a calibration check be performed on a daily basis however calibration will 
be performed before each and every subject to further insure accuracy and reliability of results.  
A standard 3-liter calibration syringe model #P-000300-000 manufactured by the Puritan-
Bennett Corporation will be used. The following procedure will be used to calibrate the 
spirometer. 
1. The FSII flow sensor will be connected to the spirometer via the     
pressure tubing. 
2. The Renaissance II spirometer will be turned on. 
3. When the CAL NOW screen appears YES will be pressed. 
4. The numeric code on the flow sensor will be entered. 
5. Verification or correction of the barometric will be made. 
6. The calibration syringe will be connected to the spirometer. 
7. Begin with the plunger of the calibration syringe fully extended, press the 
PROCEED key, and push the plunger in slowly and smoothly over a time 
period of approximately one to two seconds. 
8. The DONE key will be pressed. 
9. Pull the plunger fully out to the fully extended position again and repeat steps 
7 and 8 to perform an INSPIRATORY CAL  
10. If the calibration was successful the syringe volume, measured volume, and 
error percent will be displayed on the final screen. 
11. If the calibration was not successful repeat steps 7 through 9. 
12.  Once a successful calibration is attained press DONE to save the 
calibration check and then PRINT to print out a record of the results. 
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APPENDIX E 
 
Sample Spirometery Report 
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APPENDIX F 
 
 
SUBJECT DATA TABLE KEY 
 
A  Subject  (1 = Runners, 2 = Non-runners) 
 
B  Age (years) 
 
C  Height (inches) 
 
D  Weight (pounds) 
 
E  Body Mass Index  
 
F  Negative Inspiratory Force (cmH2O) 
 
G  Positive Expiratory Force (cmH2O) 
 
  H  Actual Forced Vital Capacity (liters) 
 
  I  Actual Forced Expiratory Volume One Second (liters) 
 
  J  Actual Forced Expiratory Flow25-75% (liters per second) 
   
  K  Actual Peak Expiratory Flow (liters per second) 
 
  L Actual Maximum Voluntary Ventilation (liters per minute) 
 
  M  Relative Forced Vital Capacity (liters) 
 
  N  Relative Forced Expiratory Volume One Second (liters) 
 
  O  Relative Forced Expiratory Flow25-75% (liters per second) 
   
  P  Relative Peak Expiratory Flow (liters per second) 
 
  Q  Relative Maximum Voluntary Ventilation (liters per minute) 
 
  R  Percent Predicted Forced Vital Capacity  
 
  S  Percent Predicted Forced Expiratory Volume One Second  
 
  T  Percent Predicted Forced Expiratory Flow25-75% 
   
  U  Percent Predicted Peak Expiratory Flow  
 
  V  Percent Predicted Maximum Voluntary Ventilation  
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Sub A B C D E F G H I J K L M N O P Q R S T U V
1 1 46 70 168 24.2 139 199 6.29 5.30 4.43 13.03 210 3.54 2.98 2.49 7.33 118 129 133 107 142 153
2 1 46 72 175 23.8 140 95 5.08 4.30 4.31 11.49 197 2.78 2.35 2.36 6.28 108 96 99 97 119 138
3 1 47 72 170 23.1 142 203 6.57 5.16 4.76 8.80 172 3.59 2.82 2.60 4.81 94 124 120 108 92 121
4 1 49 71 163 22.8 112 250 6.35 4.33 3.02 8.75 179 3.52 2.40 1.67 4.85 99 132 111 75 96 133
5 1 49 72 193 26.2 75 94 5.76 3.21 2.16 8.93 112 3.15 1.76 1.18 4.88 61 116 79 69 61 81
6 1 50 69 190 28.1 128 154 4.68 3.37 2.29 8.59 137 2.67 1.92 1.31 4.90 78 106 94 62 99 106
7 1 51 64 148 25.5 101 77 4.20 3.04 2.02 9.41 162 2.58 1.87 1.24 5.79 100 121 107 65 124 141
8 1 53 69 145 21.5 110 64 4.68 3.37 2.29 8.59 137 2.88 2.07 1.41 5.28 78 106 94 62 99 106
9 1 55 69 155 22.9 145 183 5.31 3.46 2.09 7.78 152 3.03 1.97 1.19 4.44 87 122 98 57 91 120
10 1 58 67 172 27 140 184 4.56 3.38 2.35 10.68 174 2.68 1.99 1.38 6.28 102 125 115 76 138 118
11 1 58 67 160 25.1 140 117 5.30 4.15 3.68 9.41 154 3.11 2.44 2.16 5.53 91 138 133 114 118 131
12 1 58 69 190 28.1 103 116 5.17 3.80 2.64 9.73 184 2.95 2.17 1.51 5.55 105 114 104 71 111 144
13 1 59 73 203 26.8 139 141 5.70 4.55 4.26 10.73 161 3.07 2.45 2.30 5.79 87 112 111 105 115 119
14 1 61 63 152 27 132 181 4.46 3.12 1.84 8.23 169 2.79 1.95 1.15 5.14 106 153 133 73 119 164
15 1 61 69 170 25.3 108 99 5.09 3.65 2.57 8.34 159 2.90 2.08 1.47 4.76 91 122 109 75 100 130
16 1 62 65 135 22.5 111 208 4.71 3.82 3.86 6.86 146 2.85 2.31 2.34 4.16 88 142 144 138 93 134
17 1 62 70 179 25.7 136 88 4.34 3.79 5.17 9.32 137 2.44 2.13 2.91 5.24 77 98 107 146 108 110
18 1 64 67 145 22.8 106 198 4.52 3.60 3.28 7.01 128 2.66 2.12 1.93 4.12 75 123 123 109 90 113
19 1 65 72 165 22.4 58 67 6.30 4.53 3.06 10.20 167 3.44 2.48 1.67 5.58 91 133 120 82 114 130
20 1 65 73 234 30.9 95 160 4.73 3.31 1.97 8.00 160 2.55 1.79 1.06 4.31 86 100 87 52 89 126
21 2 45 68 190 28.9 82 127 4.70 3.71 3.51 7.78 136 2.72 2.15 2.03 4.50 79 105 100 90 89 103
22 2 45 76 310 37.8 300 235 6.07 4.68 4.16 9.56 169 3.14 2.42 2.15 4.95 88 98 93 82 90 109
23 2 49 67 155 24.3 61 65 4.44 3.20 2.18 8.09 131 2.61 1.88 1.28 4.75 77 108 95 61 97 104
24 2 49 69 170 25.2 80 76 4.84 4.11 4.94 11.00 162 2.76 2.35 2.82 6.28 92 106 111 128 125 123
25 2 49 73 190 25.1 146 207 5.74 4.03 2.63 9.80 139 3.10 2.17 1.42 5.29 75 106 92 59 101 97
26 2 50 69 200 29.6 126 200 5.78 4.43 3.90 7.53 167 3.30 2.53 2.23 4.30 95 128 120 102 86 128
27 2 50 70 210 30.2 123 154 4.96 3.89 3.76 7.65 159 2.79 2.19 2.11 4.30 89 104 101 95 85 119
28 2 52 73 285 37.7 99 66 4.77 4.12 5.55 10.13 144 2.57 2.22 2.99 5.46 78 93 99 132 107 104
29 2 53 67 195 30.6 75 67 5.31 3.58 2.92 8.13 107 3.12 2.10 1.72 4.78 63 133 110 50 99 87
30 2 53 69 216 32 126 141 4.73 3.59 3.03 6.35 123 2.70 2.05 1.73 3.62 70 107 101 82 74 95
31 2 53 70 240 34.5 80 93 4.89 3.95 4.28 6.43 136 2.75 2.22 2.41 3.62 77 104 104 110 72 102
32 2 53 71 190 26.6 104 186 4.37 2.91 1.79 7.07 124 2.42 1.61 0.99 3.92 69 112 92 53 104 111
33 2 53 73 184 24.3 117 142 5.55 4.10 2.99 11.46 159 2.99 2.21 1.61 6.18 86 105 96 69 120 113
34 2 54 68 160 24.4 116 146 4.51 3.35 2.48 9.12 144 2.61 1.94 1.44 5.28 83 107 98 69 108 116
35 2 55 70 225 32.4 114 248 5.36 3.78 2.60 8.91 167 3.01 2.13 1.46 5.01 94 116 101 68 101 129
36 2 56 69 208 30.8 203 98 4.69 3.81 3.97 11.07 181 2.68 2.17 2.27 6.32 103 108 109 100 130 144
37 2 56 70 200 28.8 103 181 4.22 3.33 3.15 9.99 105 2.37 1.87 1.77 5.62 59 92 90 83 113 82
38 2 57 69 225 33.3 73 116 4.89 3.64 2.91 7.20 151 2.79 2.08 1.66 4.11 86 114 105 82 85 121
39 2 61 69 189 28 102 112 5.35 3.84 2.67 9.86 135 3.05 2.19 1.52 5.63 77 128 115 78 92 111
40 2 62 74 200 25.7 110 187 4.74 3.56 2.73 10.50 158 2.52 1.89 1.45 5.59 84 90 85 66 110 116
SUBJECT DATA TABLE 
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SUBJECT AG E HEIG HT WEIG HT BM I NIF PEForce
SUBJECT Pearson Correl 1.00 -0.28 0.20 0.51 0.55 -0.01 -0.01
N = 40 Sig. (2-tailed) . 0.08 0.22 0.00 0.00 0.94 0.93
AG E Pearson Correl -0.28 1.00 -0.19 -0.19 -0.13 -0.22 -0.06
N = 40 Sig. (2-tailed) 0.08 . 0.24 0.25 0.41 0.18 0.70
HEIG HT Pearson Correl 0.20 -0.19 1.00 0.61 0.24 0.29 0.16
N = 40 Sig. (2-tailed) 0.22 0.24 . 0.00 0.13 0.07 0.31
WEIG HT Pearson Correl 0.51 -0.19 0.61 1.00 0.92 0.34 0.07
N = 40 Sig. (2-tailed) 0.00 0.25 0.00 . 0.00 0.03 0.68
BM I Pearson Correl 0.55 -0.13 0.24 0.92 1.00 0.23 -0.02
N = 40 Sig. (2-tailed) 0.00 0.41 0.13 0.00 . 0.15 0.92
NIF Pearson Correl -0.01 -0.22 0.29 0.34 0.23 1.00 0.44
N = 40 Sig. (2-tailed) 0.94 0.18 0.07 0.03 0.15 . 0.00
PEForce Pearson Correl -0.01 -0.06 0.16 0.07 -0.02 0.44 1.00
N = 40 Sig. (2-tailed) 0.93 0.70 0.31 0.68 0.92 0.00 .
ACT FVC Pearson Correl -0.16 -0.29 0.50 0.12 -0.10 0.23 0.30
N = 40 Sig. (2-tailed) 0.34 0.07 0.00 0.48 0.53 0.15 0.06
ACT FEV1 Pearson Correl -0.08 -0.29 0.45 0.19 0.00 0.35 0.21
N = 40 Sig. (2-tailed) 0.64 0.07 0.00 0.25 1.00 0.03 0.18
ACT FEF25-75 Pearson Correl 0.10 -0.23 0.29 0.31 0.23 0.25 -0.10
N = 40 Sig. (2-tailed) 0.52 0.16 0.07 0.05 0.16 0.13 0.55
ACT PEFlow Pearson Correl -0.10 -0.12 0.33 -0.01 -0.18 0.26 -0.09
N = 40 Sig. (2-tailed) 0.53 0.45 0.04 0.96 0.28 0.11 0.57
ACT M VV Pearson Correl -0.33 -0.10 0.12 -0.04 -0.12 0.38 0.24
N = 40 Sig. (2-tailed) 0.04 0.54 0.45 0.80 0.46 0.02 0.14
 REL FVC Pearson Correl -0.26 -0.26 0.21 -0.10 -0.22 0.15 0.26
N = 40 Sig. (2-tailed) 0.11 0.11 0.19 0.54 0.17 0.36 0.11
REL FEV1 Pearson Correl -0.16 -0.26 0.20 0.01 -0.09 0.28 0.17
N = 40 Sig. (2-tailed) 0.34 0.11 0.22 0.96 0.56 0.08 0.30
REL FEF25-75 Pearson Correl 0.08 -0.20 0.18 0.23 0.19 0.21 -0.13
N = 40 Sig. (2-tailed) 0.62 0.21 0.28 0.15 0.25 0.20 0.44
REL PEFlow Pearson Correl -0.17 -0.09 0.10 -0.17 -0.26 0.20 -0.16
N = 40 Sig. (2-tailed) 0.29 0.58 0.53 0.30 0.11 0.22 0.34
REL M VV Pearson Correl -0.38 -0.05 -0.14 -0.20 -0.18 0.30 0.19
N = 40 Sig. (2-tailed) 0.02 0.78 0.38 0.22 0.27 0.06 0.23
% FVC Pearson Correl -0.43 0.24 -0.59 -0.53 -0.36 -0.11 0.18
N = 40 Sig. (2-tailed) 0.01 0.13 0.00 0.00 0.02 0.50 0.27
% FEV1 Pearson Correl -0.36 0.26 -0.54 -0.43 -0.27 0.04 0.13
N = 40 Sig. (2-tailed) 0.02 0.11 0.00 0.01 0.09 0.82 0.41
% FEF25-75 Pearson Correl -0.09 0.04 -0.03 0.04 0.06 0.11 -0.09
N = 40 Sig. (2-tailed) 0.60 0.79 0.84 0.79 0.73 0.50 0.58
% PEFlow Pearson Correl -0.19 0.09 -0.15 -0.28 -0.28 0.18 -0.06
N = 40 Sig. (2-tailed) 0.24 0.57 0.36 0.08 0.08 0.27 0.72
% M VV Pearson Correl -0.42 0.20 -0.30 -0.30 -0.23 0.19 0.17
N = 40 Sig. (2-tailed) 0.01 0.22 0.06 0.06 0.15 0.23 0.30
M ILS  WK Pearson Correl . -0.06 -0.10 -0.36 -0.42 -0.21 0.03
N = 20 Sig. (2-tailed) . 0.81 0.68 0.12 0.06 0.37 0.90
YRS RUN Pearson Correl . 0.41 -0.12 0.21 0.34 -0.13 -0.16
N = 20 Sig. (2-tailed) . 0.07 0.63 0.38 0.14 0.60 0.50
M ARATH Pearson Correl . -0.13 0.21 -0.21 -0.45 -0.30 0.22
N = 20 Sig. (2-tailed) . 0.58 0.38 0.37 0.05 0.20 0.35
10K PR Pearson Correl . 0.16 0.16 0.58 0.66 -0.08 0.05
N = 20 Sig. (2-tailed) . 0.50 0.50 0.01 0.00 0.73 0.84
5K PR Pearson Correl . 0.15 0.19 0.52 0.57 -0.09 0.01
N = 20 Sig. (2-tailed) . 0.53 0.43 0.02 0.01 0.71 0.95
Correlation is significant at the 0.01 level (2-tailed).
Correlation is significant at the 0.05 level (2-tailed).
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 ACTUAL ACTUAL ACTUAL ACTUAL ACTUAL 
FVC FEV1 FEF25-75 PEFlow M VV
SUBJECT Pearson Correlation -0.16 -0.08 0.10 -0.10 -0.33
N = 40 Sig. (2-tailed) 0.34 0.64 0.52 0.53 0.04
AGE Pearson Correlation -0.29 -0.29 -0.23 -0.12 -0.10
N = 40 Sig. (2-tailed) 0.07 0.07 0.16 0.45 0.54
HEIGHT Pearson Correlation 0.50 0.45 0.29 0.33 0.12
N = 40 Sig. (2-tailed) 0.00 0.00 0.07 0.04 0.45
WEIGHT Pearson Correlation 0.12 0.19 0.31 -0.01 -0.04
N = 40 Sig. (2-tailed) 0.48 0.25 0.05 0.96 0.80
BM I Pearson Correlation -0.10 0.00 0.23 -0.18 -0.12
N = 40 Sig. (2-tailed) 0.53 1.00 0.16 0.28 0.46
NIF Pearson Correlation 0.23 0.35 0.25 0.26 0.38
N = 40 Sig. (2-tailed) 0.15 0.03 0.13 0.11 0.02
PEForce Pearson Correlation 0.30 0.21 -0.10 -0.09 0.24
N = 40 Sig. (2-tailed) 0.06 0.18 0.55 0.57 0.14
ACT FVC Pearson Correlation 1.00 0.79 0.25 0.28 0.41
N = 40 Sig. (2-tailed) . 0.00 0.13 0.08 0.01
ACT FEV1 Pearson Correlation 0.79 1.00 0.71 0.43 0.57
N = 40 Sig. (2-tailed) 0.00 . 0.00 0.01 0.00
ACT FEF25-75 Pearson Correlation 0.25 0.71 1.00 0.29 0.25
N = 40 Sig. (2-tailed) 0.13 0.00 . 0.07 0.12
ACT PEFlow Pearson Correlation 0.28 0.43 0.29 1.00 0.53
N = 40 Sig. (2-tailed) 0.08 0.01 0.07 . 0.00
ACT M VV Pearson Correlation 0.41 0.57 0.25 0.53 1.00
N = 40 Sig. (2-tailed) 0.01 0.00 0.12 0.00 .
 REL FVC Pearson Correlation 0.95 0.72 0.16 0.20 0.41
N = 40 Sig. (2-tailed) 0.00 0.00 0.31 0.22 0.01
REL FEV1 Pearson Correlation 0.72 0.96 0.69 0.37 0.58
N = 40 Sig. (2-tailed) 0.00 0.00 0.00 0.02 0.00
REL FEF25-75 Pearson Correlation 0.19 0.68 0.99 0.25 0.23
N = 40 Sig. (2-tailed) 0.24 0.00 0.00 0.13 0.15
REL PEFlow Pearson Correlation 0.17 0.33 0.21 0.97 0.52
N = 40 Sig. (2-tailed) 0.31 0.04 0.19 0.00 0.00
REL M VV Pearson Correlation 0.27 0.44 0.16 0.44 0.96
N = 40 Sig. (2-tailed) 0.09 0.00 0.31 0.00 0.00
% FVC Pearson Correlation 0.30 0.10 -0.22 -0.16 0.18
N = 40 Sig. (2-tailed) 0.06 0.55 0.18 0.31 0.27
% FEV1 Pearson Correlation 0.19 0.40 0.30 0.02 0.36
N = 40 Sig. (2-tailed) 0.24 0.01 0.06 0.92 0.02
% FEF25-75 Pearson Correlation 0.02 0.50 0.88 0.12 0.17
N = 40 Sig. (2-tailed) 0.89 0.00 0.00 0.46 0.28
% PEFlow Pearson Correlation -0.09 0.16 0.12 0.77 0.53
N = 40 Sig. (2-tailed) 0.58 0.31 0.45 0.00 0.00
% M VV Pearson Correlation 0.12 0.26 0.04 0.26 0.84
N = 40 Sig. (2-tailed) 0.46 0.11 0.82 0.10 0.00
M ILS  WK Pearson Correlation 0.16 0.18 0.30 -0.17 -0.15
N = 20 Sig. (2-tailed) 0.49 0.46 0.20 0.48 0.52
YRS RUN Pearson Correlation -0.41 -0.37 -0.11 -0.33 -0.36
N = 20 Sig. (2-tailed) 0.07 0.11 0.64 0.16 0.12
M ARATH Pearson Correlation 0.52 0.32 0.07 -0.06 0.18
N = 20 Sig. (2-tailed) 0.02 0.17 0.77 0.79 0.45
10K PR Pearson Correlation -0.09 -0.15 -0.22 0.28 0.21
N = 20 Sig. (2-tailed) 0.70 0.53 0.36 0.23 0.37
5K PR Pearson Correlation -0.06 -0.12 -0.12 0.33 0.15
N = 20 Sig. (2-tailed) 0.79 0.60 0.62 0.15 0.52
Correlation is significant at the 0.01 level (2-tailed).
Correlation is significant at the 0.05 level (2-tailed).
Correlation Matrix 
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 RELATIVE RELATIVE RELATIVE RELATIVE RELATIVE 
FVC FEV1 FEF25-75 PEFlow M VV
SUBJECT Pearson Correlation -0.26 -0.16 0.08 -0.17 -0.38
N = 40 Sig. (2-tailed) 0.11 0.34 0.62 0.29 0.02
AGE Pearson Correlation -0.26 -0.26 -0.20 -0.09 -0.05
N = 40 Sig. (2-tailed) 0.11 0.11 0.21 0.58 0.78
HEIGHT Pearson Correlation 0.21 0.20 0.18 0.10 -0.14
N = 40 Sig. (2-tailed) 0.19 0.22 0.28 0.53 0.38
WEIGHT Pearson Correlation -0.10 0.01 0.23 -0.17 -0.20
N = 40 Sig. (2-tailed) 0.54 0.96 0.15 0.30 0.22
BM I Pearson Correlation -0.22 -0.09 0.19 -0.26 -0.18
N = 40 Sig. (2-tailed) 0.17 0.56 0.25 0.11 0.27
NIF Pearson Correlation 0.15 0.28 0.21 0.20 0.30
N = 40 Sig. (2-tailed) 0.36 0.08 0.20 0.22 0.06
PEForce Pearson Correlation 0.26 0.17 -0.13 -0.16 0.19
N = 40 Sig. (2-tailed) 0.11 0.30 0.44 0.34 0.23
ACT FVC Pearson Correlation 0.95 0.72 0.19 0.17 0.27
N = 40 Sig. (2-tailed) 0.00 0.00 0.24 0.31 0.09
ACT FEV1 Pearson Correlation 0.72 0.96 0.68 0.33 0.44
N = 40 Sig. (2-tailed) 0.00 0.00 0.00 0.04 0.00
ACT FEF25-75 Pearson Correlation 0.16 0.69 0.99 0.21 0.16
N = 40 Sig. (2-tailed) 0.31 0.00 0.00 0.19 0.31
ACT PEFlow Pearson Correlation 0.20 0.37 0.25 0.97 0.44
N = 40 Sig. (2-tailed) 0.22 0.02 0.13 0.00 0.00
ACT M VV Pearson Correlation 0.41 0.58 0.23 0.52 0.96
N = 40 Sig. (2-tailed) 0.01 0.00 0.15 0.00 0.00
 REL FVC Pearson Correlation 1.00 0.74 0.14 0.15 0.35
N = 40 Sig. (2-tailed) . 0.00 0.38 0.34 0.03
REL FEV1 Pearson Correlation 0.74 1.00 0.69 0.33 0.51
N = 40 Sig. (2-tailed) 0.00 . 0.00 0.04 0.00
REL FEF25-75 Pearson Correlation 0.14 0.69 1.00 0.20 0.18
N = 40 Sig. (2-tailed) 0.38 0.00 . 0.21 0.28
REL PEFlow Pearson Correlation 0.15 0.33 0.20 1.00 0.50
N = 40 Sig. (2-tailed) 0.34 0.04 0.21 . 0.00
REL M VV Pearson Correlation 0.35 0.51 0.18 0.50 1.00
N = 40 Sig. (2-tailed) 0.03 0.00 0.28 0.00 .
% FVC Pearson Correlation 0.53 0.28 -0.15 -0.04 0.34
N = 40 Sig. (2-tailed) 0.00 0.08 0.34 0.82 0.03
% FEV1 Pearson Correlation 0.39 0.59 0.38 0.13 0.50
N = 40 Sig. (2-tailed) 0.01 0.00 0.02 0.42 0.00
% FEF25-75 Pearson Correlation 0.02 0.56 0.91 0.12 0.18
N = 40 Sig. (2-tailed) 0.89 0.00 0.00 0.48 0.27
% PEFlow Pearson Correlation -0.06 0.22 0.14 0.85 0.58
N = 40 Sig. (2-tailed) 0.73 0.18 0.40 0.00 0.00
% M VV Pearson Correlation 0.23 0.36 0.07 0.35 0.92
N = 40 Sig. (2-tailed) 0.15 0.02 0.68 0.03 0.00
M ILS  WK Pearson Correlation 0.19 0.21 0.32 -0.18 -0.13
N = 20 Sig. (2-tailed) 0.42 0.38 0.16 0.46 0.60
YRS RUN Pearson Correlation -0.43 -0.36 -0.09 -0.29 -0.31
N = 20 Sig. (2-tailed) 0.06 0.12 0.70 0.21 0.18
M ARATH Pearson Correlation 0.53 0.29 0.04 -0.13 0.11
N = 20 Sig. (2-tailed) 0.02 0.22 0.87 0.59 0.64
10K PR Pearson Correlation -0.19 -0.23 -0.25 0.23 0.18
N = 20 Sig. (2-tailed) 0.41 0.32 0.28 0.32 0.46
5K PR Pearson Correlation -0.17 -0.21 -0.16 0.28 0.11
N = 20 Sig. (2-tailed) 0.48 0.37 0.51 0.23 0.64
Correlation is significant at the 0.01 level (2-tailed).
Correlation is significant at the 0.05 level (2-tailed).
Correlation Matrix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 62 
 
 
 
 
 
 % PRED % PRED % PRED % PRED % PRED
FVC FEV1 FEF25-75 PEFlow M VV
SUBJECT Pearson Correlation -0.43 -0.36 -0.09 -0.19 -0.42
N = 40 Sig. (2-tailed) 0.01 0.02 0.60 0.24 0.01
AGE Pearson Correlation 0.24 0.26 0.04 0.09 0.20
N = 40 Sig. (2-tailed) 0.13 0.11 0.79 0.57 0.22
HEIGHT Pearson Correlation -0.59 -0.54 -0.03 -0.15 -0.30
N = 40 Sig. (2-tailed) 0.00 0.00 0.84 0.36 0.06
WEIGHT Pearson Correlation -0.53 -0.43 0.04 -0.28 -0.30
N = 40 Sig. (2-tailed) 0.00 0.01 0.79 0.08 0.06
BM I Pearson Correlation -0.36 -0.27 0.06 -0.28 -0.23
N = 40 Sig. (2-tailed) 0.02 0.09 0.73 0.08 0.15
NIF Pearson Correlation -0.11 0.04 0.11 0.18 0.19
N = 40 Sig. (2-tailed) 0.50 0.82 0.50 0.27 0.23
PEForce Pearson Correlation 0.18 0.13 -0.09 -0.06 0.17
N = 40 Sig. (2-tailed) 0.27 0.41 0.58 0.72 0.30
ACT FVC Pearson Correlation 0.30 0.19 0.02 -0.09 0.12
N = 40 Sig. (2-tailed) 0.06 0.24 0.89 0.58 0.46
ACT FEV1 Pearson Correlation 0.10 0.40 0.50 0.16 0.26
N = 40 Sig. (2-tailed) 0.55 0.01 0.00 0.31 0.11
ACT FEF25-75 Pearson Correlation -0.22 0.30 0.88 0.12 0.04
N = 40 Sig. (2-tailed) 0.18 0.06 0.00 0.45 0.82
ACT PEFlow Pearson Correlation -0.16 0.02 0.12 0.77 0.26
N = 40 Sig. (2-tailed) 0.31 0.92 0.46 0.00 0.10
ACT M VV Pearson Correlation 0.18 0.36 0.17 0.53 0.84
N = 40 Sig. (2-tailed) 0.27 0.02 0.28 0.00 0.00
 REL FVC Pearson Correlation 0.53 0.39 0.02 -0.06 0.23
N = 40 Sig. (2-tailed) 0.00 0.01 0.89 0.73 0.15
REL FEV1 Pearson Correlation 0.28 0.59 0.56 0.22 0.36
N = 40 Sig. (2-tailed) 0.08 0.00 0.00 0.18 0.02
REL FEF25-75 Pearson Correlation -0.15 0.38 0.91 0.14 0.07
N = 40 Sig. (2-tailed) 0.34 0.02 0.00 0.40 0.68
REL PEFlow Pearson Correlation -0.04 0.13 0.12 0.85 0.35
N = 40 Sig. (2-tailed) 0.82 0.42 0.48 0.00 0.03
REL M VV Pearson Correlation 0.34 0.50 0.18 0.58 0.92
N = 40 Sig. (2-tailed) 0.03 0.00 0.27 0.00 0.00
% FVC Pearson Correlation 1.00 0.79 0.01 0.10 0.47
N = 40 Sig. (2-tailed) . 0.00 0.95 0.56 0.00
% FEV1 Pearson Correlation 0.79 1.00 0.53 0.31 0.59
N = 40 Sig. (2-tailed) 0.00 . 0.00 0.05 0.00
% FEF25-75 Pearson Correlation 0.01 0.53 1.00 0.12 0.16
N = 40 Sig. (2-tailed) 0.95 0.00 . 0.48 0.31
% PEFlow Pearson Correlation 0.10 0.31 0.12 1.00 0.52
N = 40 Sig. (2-tailed) 0.56 0.05 0.48 . 0.00
% M VV Pearson Correlation 0.47 0.59 0.16 0.52 1.00
N = 40 Sig. (2-tailed) 0.00 0.00 0.31 0.00 .
M ILS  WK Pearson Correlation 0.30 0.33 0.44 -0.18 -0.12
N = 20 Sig. (2-tailed) 0.20 0.15 0.05 0.46 0.63
YRS RUN Pearson Correlation -0.06 -0.05 0.05 -0.15 -0.05
N = 20 Sig. (2-tailed) 0.81 0.84 0.83 0.54 0.85
M ARATH Pearson Correlation 0.26 0.10 -0.04 -0.11 0.09
N = 20 Sig. (2-tailed) 0.28 0.69 0.86 0.65 0.70
10K PR Pearson Correlation -0.20 -0.25 -0.25 0.14 0.06
N = 20 Sig. (2-tailed) 0.40 0.29 0.29 0.56 0.80
5K PR Pearson Correlation -0.22 -0.25 -0.14 0.14 -0.05
N = 20 Sig. (2-tailed) 0.35 0.28 0.55 0.56 0.85
Correlation is significant at the 0.01 level (2-tailed).
Correlation is significant at the 0.05 level (2-tailed).
Correlation Matrix 
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FEV1% PERCENT PREDICTED
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